Meftal Spas Suspension

MEFTAL-SPAS® Suspension

MEFTAL-SPAS® Suspension is a paediatric antispasmodic and antifoaming formulation indicated for the symptomatic relief of abdominal pain, colicky spasms, and irritable bowel syndrome (IBS) in infants and children.

Clinical Applications

Most popular clinical applications:
Abdominal Pain

Abdominal Pain

Learn More
Irritable Bowel Syndrome

Irritable Bowel Syndrome

Learn More
Colicky Spasms

Colicky Spasms

Learn More
Bloating & Flatulence

Bloating & Flatulence

Learn More

More Clinical Application

Gastroenterology Irritable bowel syndrome (IBS) and spasmodic pain associated with enteritis or colitis in children.
Paediatrics Abdominal pain and colicky discomfort in infants above six months and young children.
General Medicine Bloating and flatulence caused by trapped intestinal gas.
Neonatology Infantile colic with excessive crying linked to gut spasms and gas in infants above six months.

Prescribing Guidelines by Age

MEFTAL-SPAS® product range is formulated to provide age-appropriate dosing across the patient lifecycle. Suspension is the preferred delivery system for infants and children who require measured, palatable dosing, while the brand offers alternate formats for other age groups.

Patient Age Group Recommended Format Typical Clinical Use
Infants (up to 6 months) Not recommended Consult a paediatrician for gripe- and colic-related discomfort.
Infants & Children (6 months – 12 years) Suspension Abdominal pain, colicky spasms, IBS, and gas-related bloating.
Adolescents (12+ years) Tablet
  • Monthly period pain and functional GI spasms.
  • Biliary, Renal, and Intestinal colic.
Adults Tablet
  • Monthly period pain and functional GI spasms.
  • Biliary, Renal, and Intestinal colic.
Adults (Acute Care) Injection Severe, sudden spasms requiring rapid onset.

Pharmacological Highlights for the Physician

  • Dual Mechanism:
    Combines the antispasmodic effect of Dicyclomine Hydrochloride (to relax intestinal smooth muscle) with the antiflatulent effect of Simethicone (to disperse trapped gas).
  • Paediatric-Friendly Design:
    Measured cup/spoon dosing for accurate, palatable administration suited to infants and young children.

Prescribing Information

Generic Name

Dicyclomine Hydrochloride & Simethicone Suspension

(Brand Name: MEFTAL-SPAS® Suspension)

Qualitative and Quantitative Composition

MEFTAL-SPAS® Suspension

Each 5ml contains:

Dicyclomine Hydrochloride IP - 10 mg

Simethicone IP - 40 mg

Dosage Form and Strength

Dosage Form: Oral Suspension.

Dosage Strength: Dicyclomine hydrochloride 10 mg + Simethicone 40 mg per 5 ml.

Posology and Method of Administration

For oral administration in infants and children, using the measuring cup or spoon provided.

  • MEFTAL-SPAS® Suspension

    Dose and frequency to be determined by the physician based on the child's age, body weight, and clinical condition.

Preferably administered before food. Shake well before use and give at the same time each day to maintain a constant level of medicine. Not to be given for more than 2 weeks without medical supervision. Or, as prescribed by the physician.

Contraindications

MEFTAL-SPAS® Suspension is contraindicated in the following

  • Known hypersensitivity to dicyclomine or simethicone or to any component of the formulation.
  • Infants below six months of age.
  • Obstructive or inflammatory bowel disease, paralytic ileus, and intestinal atony.
  • Glaucoma.
  • Myasthenia gravis
  • Urinary retention or obstructive uropathy
  • Unstable cardiovascular status.

Possible Side Effects (Safety Information)

For detailed quantitative and qualitative composition, therapeutic indications, posology and method of administration, contraindications, special warnings and precautions for use, drug interactions, undesirable effects, overdose, mechanism of action, and pharmacodynamic properties of MEFTAL-SPAS® Suspension, download the note.